Ignite Creation Date:
2024-07-17 @ 10:44 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06482788
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-05-22
Brief Title:
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy Adebrelimab Combined With Chemotherapy XELOX a Prospective Single-center Feasibility Study
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-22
First Submit QC Date:
None
Study First Post Date:
2024-07-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-27
Last Update Post Date:
2024-07-01
Last Update Post Date Type:
ACTUAL